BOOST Pharma ApS: Financial statements 2025
CVR: 41120495
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BOOST Pharma ApS (CVR 41120495) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity in the 2025 report amounted to DKK -11,850,535. The company had 2 employees in the financial year.
- Gross Profit
- DKK -7,557,572
- Profit/Loss
- DKK -9,243,488
- Equity
- DKK -11,850,535
- Total Assets
- DKK 7,206,920
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -7.6 mio. | -9.2 mio. | -11.9 mio. | 2 |
| 2024 | - | -2.2 mio. | -4.3 mio. | -7 mio. | 2 |
| 2023 | - | -1.5 mio. | -2.8 mio. | -9.2 mio. | 1 |
| 2022 | - | -3.5 mio. | -4.2 mio. | -6.4 mio. | 1 |
| 2021 | - | -1.3 mio. | -2.2 mio. | -2.2 mio. | 1 |
Official annual report
How creditworthy is BOOST Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 30, 2025, is registered as an owner of BOOST Pharma ApS with an ownership share of 100%.
As of August 22, 2025, Hans Thalsgård Schambye has joined the board of directors of BOOST Pharma ApS.
BOOST Pharma ApS has published its annual report for 2024. Gross profit came to DKK -2,193,394, and the net result was DKK -4,259,583.
About BOOST Pharma ApS
BOOST Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Thalsgård Schambye. The company is owned by BOOST Pharma AB. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity in the 2025 report amounted to DKK -11,850,535.